Table 1 Patient characteristics (* pro-BNP was not measured routinely; abbreviations see text)
Contrast-enhanced TEE | Control group | p value | |
|---|---|---|---|
n | 90 | 90 | |
Age | 65.9±12 | 64.5±13 | 0.474 |
female, % | 32.2 | 24.4 | 0.247 |
BMI, kg/m2 | 27.9±5.0 | 26.2±4.1 | 0.111 |
history of TIA/Stroke, % | 4.8 | 2.7 | 0.522 |
COPD ≥ °II, % | 4.8 | 8.2 | 0.433 |
diabetes mellitus, % | 21.3 | 13.7 | 0.244 |
hypertension, % | 58.7 | 60.3 | 0.855 |
CAD, % | 27.7 | 28 | 0.968 |
previous.MI, % | 4.8 | 6.8 | 0.606 |
hyperlipoproteinemia, % | 20.6 | 20.3 | 0.958 |
heart rate 1/min | 91.7±26 | 92.8±24 | 0.803 |
antiocoagulation ≥1 day (prior to TEE, %) | 51 | 48 | 0.764 |
antiocoagulation ≥3w (prior to TEE, %) | 13 | 11 | 0.544 |
hemoglobinn (g/dl) | 14.2±1.7 | 14.3±1.7 | 0.834 |
pro-BNP (pg/ml) * | 1817±1700* | * | * |
creatinine (mg/dl) | 1.1±0.49 | 1.1±0.28 | 0.728 |
potassium (mmol/l) | 4.2±0.43 | 4.2±0.43 | 0.928 |
C-reactive protein (mg/dl) | 1.1±2.1 | 1.5±2.9 | 0.377 |